2017 American Transplant Congress Archives - Page 180 of 181

What Are “Normal” CSF Findings in the Non-Infected Brain Dead Organ Donor?

R. Steiner,^1,2 C. Wainaina,² J. Tragaser,² L. Stocks.²
When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.

S. Yamanaga,^1,2,3 A. Posselt,¹ C. Freise,¹ C. Niemann,¹ A. Rosario,¹ D. Fernandez,¹ T. Kobayashi,³ A. Ahearn,⁴ M. Tavakol,¹ S.-M. Kang.¹
Which Is More Nephrotoxic to Kidney Transplants: BK Nephropathy or Rejection?

S. Parajuli, B. Astor, D. Kaufman, B. Muth, M. Mohamed, N. Garg, A. Djamali, D. Mandelbrot.
Which Tr1 Is Better for Transplant Tolerance Induction: Comparing the Tr1 Generated by IL-27 or TGF-βplus IL-27.

G. Gu, H. Hang, Q. Xia.
Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis.

K. Yoon, K.-W. Lee, H. Kim, D. Oh, H.-S. Kim, S. Ahn, S. Hong, N.-J. Yi, K.-S. Suh.
WHO Group II Pulmonary Hypertension Is Associated with Decreased Survival in Patients Awaiting Liver Transplantation.

H. Memon, J.-A. Guerra, B. Trachtenberg, J. Estep, A. Bhimaraj, I. Hussain, M. Park, H. Monsour, M. Ghobrial, A. Guha.
Willingness of Canadian ESRD Patients to Consider Transplant Tourism.

J. Gill, G. Gill, Y. Joffres, C. Rose, J. Gill, L. Russell, A. Levin, C. Richardson.
Willingness of End-Stage Renal Disease Patients (ESRD) without Hepatitis C (HCV) to Accept a HCV+ Kidney.

P. Reese,¹ D. Goldberg,¹ A. Mussell,¹ M. McCauley,¹ D. Sawinski,¹ N. Molina,² R. Tomlin,² S. Doshi,¹ P. Abt,¹ E. Blumberg,¹ C. Thiessen,² S. Kulkarni,² G. Esnaola.²
Willingness to Donate Organs Among Persons Living with HIV.

S. Halpern, K. Kumar, A. Nguyen, S. Rasmussen, S. Anjum, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.
Women Are Delisted for Being Too Sick for Liver Transplant More Frequently Than Men.

G. Cullaro, J. Lai.